Oxidative stress in patients affected by primary aldosteronism-Reference-Cited by-同舟云学术

Oxidative stress in patients affected by primary aldosteronism

Published:2014-10 Issue:10 Volume:32 Page:2022-2029
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Petramala Luigi,Pignatelli Pasquale,Carnevale Roberto,Zinnamosca Laura,Marinelli Cristiano,Settevendemmie Amina,Concistrè Antonio,Tonnarini Gianfranco,De Toma Giorgio,Violi Francesco,Letizia Claudio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference40 articles.

1. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.;Rossi;J Am Coll Cardiol,2006

2. Adrenocortical causes of hypertension.;Moraitis;Int J Hypertens,2011

3. Primary aldosteronism: part II: subtype differentiation and treatment.;Rossi;J Nephrol,2008

4. Cardiovascular outcomes in patients with primary aldosteronism after treatment.;Catena;Arch Intern Med,2008

5. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.;Milliez;J Am Coll Cardiol,2005

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relevance of obesity-related organ damage and metabolic syndrome classification in cardiovascular and renal risk stratification in patients with essential hypertension;Frontiers in Cardiovascular Medicine;2024-03-28

2. Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism;Endocrine;2024-03-06

3. Vitamin D3 and Omega-3 Fatty Acids: A New Approach for Cardiovascular Prevention;Journal of Cardiovascular Pharmacology;2023-04

4. Hypertensive emergency occurred due to forgetting to take antihypertensive medication: A case study;SAGE Open Medical Case Reports;2023-01

5. Association between Use of Spironolactone and Risk of Stroke in Hypertensive Patients: A Cohort Study;Pharmaceuticals;2022-12-30